首页|莪术醇通过调控磷酯酰肌醇3激酶/蛋白激酶B信号通路对胶质瘤增殖与凋亡的影响

莪术醇通过调控磷酯酰肌醇3激酶/蛋白激酶B信号通路对胶质瘤增殖与凋亡的影响

扫码查看
目的 探讨莪术醇通过磷酯酰肌醇3激酶(PI3K)/蛋白激酶B(Akt)信号通路对神经胶质瘤增殖、凋亡的作用机制.方法 不同浓度莪术醇(0、25、50、100、200 μmol/L)干预人脑星形胶质母细胞瘤细胞(U87MG),观察细胞生长;细胞计数试剂盒(CCK-8)法检测细胞活力.将对数生长期U87MG细胞接种于裸鼠尾状核部位,建立胶质瘤原位模型.将模型裸鼠随机分组为模型组(等体积生理盐水)、莪术醇低剂量组(20 mg/kg)、中剂量组(40 mg/kg)和高剂量组(80 mg/kg),每组10只,连续灌胃治疗3周.观察各组小鼠行为变化;计算相对肿瘤体积、相对抑瘤率;苏木精-伊红(HE)染色观察瘤组织病理;免疫组织化学法(IHC)分析原位瘤增殖细胞核抗原(PCNA)表达及肿瘤细胞增殖指数;原位缺口末端标记法(TUNEL)染色分析肿瘤细胞凋亡水平;蛋白质印迹法(Western blot)分析PI3K/Akt信号通路相关蛋白及下游细胞周期蛋白D1(Cyclin D1)、B淋巴细胞瘤-2(bcl-2)、bcl-2相关X蛋白(bax)蛋白表达.两组间差异比较采用独立样本t检验,多组间差异比较采用One-way ANOVA分析.结果 不同浓度莪术醇干预U87MG细胞后,随着给药浓度增加细胞出现漂浮碎片,凋亡细胞数增多;CCK-8结果显示,细胞存活率分别为对照组(1.00±0.07)%,25 µmol/L 组(1.10±0.04)%,50 µmol/L 组(0.67±0.04)%,100 μmol/L 组(0.58±0.06)%,200µmol/L组(0.24±0.01)%,各给药组的细胞存活率均低于对照组,差异有统计学意义(F=323.402,P<0.05).计算瘤体体积及抑瘤率结果显示,模型组瘤体体积(42.50±27.78)mm3,各治疗组瘤体体积及抑瘤率分别为低剂量组[(31.85±20.89)mm3,25.20%],中剂量组[(21.49± 13.42)mm3,49.54%],高剂量组[(13.73±12.0)mm3,67.75%],各治疗组瘤体体积均小于模型组,差异有统计学意义(F=2.147,P<0.05),高剂量组瘤体体积明显小于模型组[(13.73± 12.05)mm3 比(42.50±27.78)mm3,t=2.130,P<0.05].IHC 结果显示,对照组、模型组、低剂量组、中剂量组、高剂量肿瘤细胞增殖指数分别(16.67±1.52)%、(40.00±1.73)%、(33.67± 2.52)%、(25.67±4.17)%、(18.00±2.64)%,各治疗组肿瘤细胞增殖指数均低于模型组,差异有统计学意义(F=32.607,P<0.05),高剂量组肿瘤细胞增殖指数明显低于模型组[(18.00±2.64)%比(40.00±1.73)%,t=12.050,P<0.05].TUNEL染色结果显示对照组、模型组、低剂量组、中剂量组、高剂量组肿瘤细胞凋亡率分别为(65.80±4.37)%、(13.47±1.87)%、(23.13±4.17)%、(38.57±5.85)%、(53.00±5.70)%,各治疗组肿瘤细胞凋亡率均高于模型组,差异有统计学意义(F=60.625,P<0.05),高剂量组肿瘤细胞凋亡率明显高于模型组[(53.00±5.70)%比(13.47± 1.87)%,t=-11.398,P<0.05].Western blot结果显示,对照组、模型组、低剂量组、中剂量组、高剂量组 PI3K、Akt 蛋白相对表达量分别为(0.10±0.01、0.72±0.06)、(0.49±0.02、1.94±0.69)、(0.39±0.01、1.69±0.17)、(0.32±0.05、1.41±0.28)、(0.14±0.03、1.11±0.28),各治疗组PI3K、Akt相对表达量均低于模型组,差异有统计学意义(F=3.150、17.944,P<0.05),高剂量组PI3K、Akt 表达量均明显低于模型组[(0.14±0.03、1.11±0.28)比(0.49±0.02、1.94±0.69),t=2.823、4.973,P<0.05];增殖相关蛋白Cyclin D1在对照组、模型组、低剂量组、中剂量组、高剂量组中相对表达量分别为 0.33±0.07、1.12±0.08、0.89±0.14、0.71±0.10、0.50±0.10,各治疗组Cyclin D1相对表达量均低于模型组,差异有统计学意义(F=27.851,P<0.05),高剂量组Cyclin D1表达量明显低于模型组(0.50±0.10比1.12±0.08,t=8.010,P<0.05);凋亡相关蛋白bcl-2、bax在对照组、模型组、低剂量组、中剂量组、高剂量中相对表达量分别(0.42±0.02、0.95±0.08)、(1.18±0.15、0.42±0.11)、(0.96±0.16、0.51±0.13)、(0.72±0.08、0.62±0.09)、(0.57±0.08、0.73±0.10),各治疗组bcl-2表达低于模型组,bax表达高于模型组,差异有统计学意义(F=23.907、11.864,P<0.05),高剂量组 bcl-2 表达明显低于模型组(0.57±0.08 比 1.18±0.15,t=6.391,P<0.05),高剂量组 bax 表达明显高于模型组(0.73±0.10 比 0.42±0.11,t=-3.663,P<0.05).结论 莪术醇可以显著抑制胶质瘤细胞增殖,并促进其凋亡;机制可能是通过调控PI3K/Akt信号通路发挥抗肿瘤作用.
Effect of curcomol on proliferation and apoptosis of glioma by regulating the phosphatidylinositol 3 kinase/protein kinase B signaling pathway
Objective To explore the mechanism of curcumol on proliferation and apoptosis of gli-oma through phosphatidylinositol 3 kinase/protein kinase B(PI3K/Akt)signaling pathway.Methods Different concentrations of curcumol(0,25,50,100,200 µmol/L)were used to intervene human astro-blastoma cells(U87MG)and the cell growth was observed by researcher;In addition,the cell viability was tested by cell counting kit(CCK-8).Logarithmic U87MG cells were inoculated into caudate nucleus of nude mice which is contribute to establish glioma in situ model.In terms of the model nude mice,which were randomly divided into model group(equal volume of saline),low dose of curcumol group(20 mg/kg),middle dose of curcumol group(40 mg/kg)and high dose of curcumol group(80 mg/kg),10 mice in each group were treated by continuous gavage for 3 weeks.And then the researcher had an observation of the changes of the mice's behavior.Calculate relative tumor volume and relative tumor inhibition rate;His-topathology of tumor was observed by hematoxylin-eosin(HE)staining;Immunohistochemical(IHC)analy-sis of proliferating cell nuclear antigen(PCNA)expression and tumor cell proliferation index;The apoptosis level of tumor cells was stained by terminal-deoxynucleotidyl transferase mediated nick end labeling(TUNEL)staining.Comparison of the expression of PI3K/Akt pathway related proteins and downstream cy-clin D1,B cell lymphoma/lewkmia-2(bcl-2)and bcl-2 related X protein(bax)protein by Western blot-ting.The independent samples ttest was used for comparison of differences between the two groups,and one-way ANOVA analysis was used for comparison of differences between multiple groups.Results After applying the method of different concentrations of curcumol to intervene human astroblastoma cells(U87MG),and with the increasing of the the dosing concentration,floating fragments appeared in cells,besides,the number of apoptotic cells increasd at the same time.CCK-8 results show that,the cell survival rate were control group(1.00±0.07)%,25 μmol/L group(1.10±0.04)%,50 μmol/L group(0.67± 0.04)%,100 µmol/L group(0.58±0.06)%,200 μmol/L group(0.24±0.01)%,respectively.The cell survival rate of each research group was lower than that of the control group,the difference was statisti-cally significant(F=323.402,P<0.05).The results of calculating tumor volume and tumor inhibition rate showed that,the tumor volume of model group was(42.50±27.78)mm3,the tumor volume and tumor inhibition rate of each treatment group were low dose of curcumol group[(31.85±20.89)mm3,25.20%],middle dosegroup[(21.49±13.42)mm3,49.54%],highdosegroup[(13.73±12.05)mm3,67.75%],respectively.The tumor volume of each group was smaller than that of the model group,the difference was statistically significant(F=2.147,P<0.05).The tumor volume of high dose of cur-cumolgroup was significantly smaller than that of model group[(13.73±12.05)mm3 vs.(42.50±27.78)mm3,t=2.130,P<0.05].IHC results showed that the tumor cell proliferation index of control group,model group,low dose of curcumol group,middle dose of curcumolgroup and high dose of curcumolgroup were(16.67±1.52)%,(40.00±1.73)%,(33.67±2.52)%,(25.67±4.17)%,(18.00±2.64)%,respectively.The tumor cell proliferation index of each treatment group was lower than that of model group,the difference was statistically significant(F=32.607,P<0.05).The proliferation index of tumor cells in the high dose group was significantly lower than that in the model group[(18.00±2.64)%vs.(40.00± 1.73)%,t=12.050,P<0.05].TUNEL staining showed that the apoptosis rates of tumor cells in each group were(65.80±4.37)%,(13.47±1.87)%,(23.13±4.17)%,(38.57±5.85)%and(53.00± 5.70)%,respectively.The apoptosis rate of tumor cells in each treatment group was higher than that in the model group,and the difference was statistically significant(F=60.625,P<0.05),what's more,the apoptosis rates of tumor cells in the high dose group were significantly higher than those in the model group[(53.00±5.70)%vs.(13.47±1.87)%,t=-11.398,P<0.05].The results of Western Blot showed that the relative expression of PI3K,Akt protein in the control group,the model group,the low dose group,the middle dose group and the high dose group were(0.10±0.01,0.72±0.06),(0.49±0.02,1.94±0.02),(0.39±0.01,1.69±0.17),(0.32±0.05,1.41±0.28),(0.14±0.03,1.11± 0.28),respectively.The relative expression of PI3K,Akt was lower than that of the model group,which indicates the difference was statistically significant(F=3.150,17.944,P<0.05).The expression of PI3K,Akt in the high dose group was lower than that of the model group[(0.14±0.03,1.11±0.28)vs.(0.49±0.02,1.94±0.69),t=2.823,4.973,P<0.05].The relative expression of Cyclin D1 in control group,model group,low dose group,middle dose group and high dose group were(0.33±0.07),(1.12±0.08),(0.89±0.14),(0.71±0.10),(0.50±0.10),respectively.The relative expressionof Cyclin D1 in each treatment group was lower than that in the model group,the difference was statistically significant(F=27.851,P<0.05).The expression of Cyclin D1 in high dose group was significantly low-er than that in model group[(0.50±0.10)vs.(1.12±0.08),t=8.010,P<0.05].Apoptosis-related protein Bcl-2,Bax was expressed(0.42±0.02,0.95±0.08),(1.18±0.15,0.42±0.11),(0.96± 0.16,0.51±0.13),(0.72±0.08,0.62±0.09),(0.57±0.08,0.73±0.10)in the control group,model group,low dose group,middle dose group and high dose group,respectively.The expression of bcl-2 was lower than that in the control group,and the expression of bax was higher than that in the control group,which also indicate that the difference was statistically significant(F=23.907,11.864,P<0.05).The expression of bcl-2 in high dose group was significantly lower than that in model group[(0.57±0.08)vs.(1.18±0.15),t=6.391,P<0.05].The expression of bax in high dose group was significantly higher than that in model group[(0.73±0.10)vs.(0.42±0.11),t=3.663,P<0.05].Conclusion Curcumol,the research target,inhibits the proliferation of glioma cells effevtively and pro-mote their apoptosissignificantly;And the mechanism of curcumol may be play an important in anti-tumor by regulating the PI3K/Akt signaling pathway.

GliomaCurcumolPhosphatidylinositol 3 kinase/protein kinase B signaling path-wayProliferationApoptosis

张慧、郑慧军、杜康、韩庆亮、吴敬强、赵晓超

展开 >

河南中医药大学第二临床医学院,郑州 450000

河南省中医院神经外科,郑州 450002

胶质瘤 莪术醇 磷酯酰肌醇3激酶/Akt信号通路 增殖 凋亡

河南省中医药科学研究专项河南省中医药科学研究专项

2022ZY20142024ZY2090

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(4)
  • 9